NCT06182579 2025-09-17
Phase I Study of RiMO-401 With Radiation in Advanced Tumors
Coordination Pharmaceuticals, Inc.
Phase 1 Terminated
Coordination Pharmaceuticals, Inc.
Basilea Pharmaceutica
Pfizer
Spectrum Pharmaceuticals, Inc
BioVex Limited
Eli Lilly and Company
Boneca Corporation